TherapeuticsMD Now Covered by Stifel Nicolaus (TXMD)
Analysts at Stifel Nicolaus assumed coverage on shares of TherapeuticsMD (NYSEMKT:TXMD) in a research report issued to clients and investors on Friday, Stock Ratings News reports. The firm set a “buy” rating and a $8.00 price target on the stock.
Shares of TherapeuticsMD (NYSEMKT:TXMD) opened at 4.78 on Friday. TherapeuticsMD has a 1-year low of $1.25 and a 1-year high of $3.70. The stock has a 50-day moving average of $3.55 and a 200-day moving average of $2.77. The company’s market cap is $692.9 million.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.